- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.05. | Sharps Technology Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 30.04. | Pre-market Movers: Regulus Therapeutics, Jeffs' Brands, INVO Fertility, GeneDx Holdings, Sharps Technology | 489 | AFX News | TEMPE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.30 A.M. ET).In the Green Regulus Therapeutics Inc. (RGLS) is up over 132%... ► Artikel lesen | |
| 30.04. | Sharps Technology Inc. - 8-K, Current Report | - | SEC Filings | ||
| 30.04. | Sharps Technology receives $400K initial purchase order | 1 | Seeking Alpha | ||
| 24.04. | Sharps Technology announces 1-for-300 reverse stock split; shares down | 6 | Seeking Alpha | ||
| SHARPS TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 24.04. | Sharps Technology Inc: Sharps Technology Announces Reverse Stock Split | 401 | GlobeNewswire (Europe) | NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: "STSS" and "STSSW") ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class... ► Artikel lesen | |
| 15.04. | Sharps Technology Inc. - 10-K/A, Annual Report | 3 | SEC Filings | ||
| 14.04. | Sharps Technology Inc. - 8-K, Current Report | 7 | SEC Filings | ||
| 04.04. | Sharps Technology Inc. - 8-K, Current Report | 9 | SEC Filings | ||
| 28.03. | Sharps Technology Inc. - 8-K, Current Report | 8 | SEC Filings | ||
| 27.03. | Sharps Technology Inc. - 10-K, Annual Report | 5 | SEC Filings | ||
| 14.03. | Sharps Technology Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 06.03. | Sharps Technology Inc: Sharps Technology's CEO Issues Corporate Update Highlighting Agreements for SecureGard and SoloGard and Revenue Developments from Manufacturing Operations in Hungary | 235 | GlobeNewswire (Europe) | NEW YORK, March 06, 2025 (GLOBE NEWSWIRE) -- Dear Fellow Shareholders, As we reflect on the progress since our December update, I am excited to share the latest developments that will shape our... ► Artikel lesen | |
| 30.01. | Sharps Technology Inc. - 8-K, Current Report | - | SEC Filings | ||
| 29.01. | Sharps Technology Inc: Sharps Technology, Inc. Announces Closing of Upsized $20.0 Million Underwritten Public Offering | 2 | GlobeNewswire (USA) | ||
| 28.01. | Sharps Technology tumbles on pricing underwritten public offering | 6 | Seeking Alpha | ||
| 28.01. | Sharps Technology sets $20 million public offering price | 5 | Investing.com | ||
| 28.01. | Sharps Technology Inc: Sharps Technology, Inc. Announces Pricing of Upsized $20.0 Million Underwritten Public Offering | 1 | GlobeNewswire (USA) | ||
| 22.01. | Sharps Technology Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| 10.01. | Sharps Technology Inc. - S-1, General form for registration of securities | 1 | SEC Filings |
Seite:
1 2 Weiter >>
32 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| STRATEC | 23,450 | -3,10 % | Nagarro, Mutares und Stratec - Wer hat die Chance auf ein SDAX-Comeback im Juni? | Nagarro, Mutares und Stratec fliegen Anfang Mai aus dem SDAX. Woran das liegt und wie die Chancen auf einen Wiederaufstieg stehen. Wer Mitglied in der DAX-Familie sein will, muss strenge Regeln erfüllen.... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,129 | -5,15 % | Sernova Biotherapeutics Inc: Sernova talks interim data from Cell Pouch trial | ||
| ATOSSA THERAPEUTICS | 0,905 | +16,32 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Full Results from I-SPY 2 Endocrine-Optimization Sub-Study Evaluating Low-Dose (Z)-Endoxifen | Feasibility endpoint achieved; rapid Ki-67 suppression and substantial MRI-confirmed tumor shrinkage observed with favorable safety profile
SEATTLE, May 14, 2025 /PRNewswire/ -- Atossa Therapeutics... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,802 | 0,00 % | Ping An Healthcare and Technology Company Limited: Ping An Health Reports 25.8% Year-on-Year Revenue Growth in Q1 2025, with Profitability Accelerating | Revenue and Profit Surge, Driven by "AI + Health Care" Value Empowerment
SHANGHAI and HONG KONG, April 24, 2025 /PRNewswire/ -- Ping An Healthcare and Technology... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,015 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,244 | -21,29 % | Co-Diagnostics GAAP EPS of -$0.24 beats by $0.03, revenue of $0.05M misses by $0.14M | ||
| CYTOSORBENTS | 0,697 | -6,82 % | Cytosorbents Corp: CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update | PRINCETON, N.J., May 14, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| VERU | 0,450 | -0,49 % | JTC Team, LLC: JTC Team Hosts Virtual Investor "KOL Connect" Segment to Discuss Veru Inc.'s Enobosarm Taking GLP-1 Weight Loss to Next Level | Moderated discussion with preeminent obesity expert Louis J. Aronne, MD, FACP and Mitchell Steiner, M.D., F.A.C.S, President, CEO, and Founder of Veru Watch the "KOL Connect" segment here FRENCHTOWN... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 7,050 | -100,00 % | Tempest Therapeutics: Tempest Reports First Quarter 2025 Financial Results and Provides Business Update | Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR Annual MeetingGranted Orphan Drug designation by FDA for TPST-1495 for the treatment... ► Artikel lesen | |
| VOLITIONRX | 0,465 | -2,52 % | VolitionRX Q1 2025 Earnings Preview | ||
| EKSO BIONICS | 0,430 | +7,50 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Accepted into NVIDIA Connect Program | ||
| IMUNON | 0,540 | -1,82 % | Imunon, Inc.: IMUNON Announces Six-Month Data Showing Durability of Protection for Next-Generation DNA Vaccine Platform in Phase 1 Clinical Trial in COVID-19 | Company's PlaCCine® technology platform demonstrates better durability and other advantages compared to mRNA vaccines Results further validate PlaCCine as a novel vaccine platform with potential applications... ► Artikel lesen | |
| BEYOND AIR | 0,170 | +3,03 % | Beyond Air: NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism | The FDA designation marks a significant milestone in the development of a novel treatment for a rare neurodevelopmental disorder Plan to initiate first-in-human U.S. clinical trials of lead drug candidate... ► Artikel lesen | |
| AVINGER | 0,340 | -6,08 % | Avinger Inc - 8-K, Current Report | ||
| FRESENIUS | 42,520 | +1,80 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 45 auf 50 Euro angehoben und die Einstufung auf "Buy" belassen. Nach dem starken Jahresstart der Aktie hätten... ► Artikel lesen |
SHARPS TECHNOLOGY INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 4,480 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHARPS TECHNOLOGY INC finden Sie auf Wallstreet Online.